Last updated 57 days ago
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
760 patients around the world
Available in Argentina, United States, Brazil
Hoffmann-La Roche
20Research sites
760Patients around the world
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Instituto de Diagnóstico e Investigaciones Metabólicas - IDIM - sede centro - CABA
Recruiting
Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja
Recruiting
Fundación CENIT para la Investigación en Neurociencias
Recruiting
Fundación Favaloro para la Docencia e Investigación Médica - CABA, Buenos Aires
Recruiting
Instituto de Ensino e Pesquisa Clinica do Ceara
Recruiting
Hospital de Caridade de Ijuí
Recruiting
CIONC - Centro Integrado de Oncología de Curitiba
Recruiting
Hospital de Câncer de Barretos - Fundação PIO XII
Recruiting
Hospital Universitario Fundacion Jimenez Diaz
Recruiting
Hospital Universitario 12 de Octubre
Recruiting
StudySKYSCRAPER-07
SponsorHoffmann-La Roche
Study typeInterventional
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT04543617
